OCABSA: A Fast-Cash Bridge Loan That Often Becomes a Shareholder Trap
A financing structure that first appeared in the United States more than 20 years ago and reached Europe around 2015 keeps returning to the financial chronicles for all the wrong reasons. Known by its French acronym OCABSA — obligations convertibles en actions avec bons de souscription d'actions — the instrument combines convertible bonds with a maturity of under three years and share subscription warrants (BSA). It is marketed as alternative funding for listed companies that can no longer borrow from banks or raise capital on acceptable terms.
The mechanics are simple on paper. Subscribing funds pay the cash at issuance, but most of them convert their bonds into shares at a price below the prevailing market price and resell those shares at once. That produces a profit for the subscriber and downward pressure on the issuer's share price — at the very moment the company is already in difficulty. The longer-dated warrants give holders the right to subscribe to new shares at a fixed price over time, gradually enlarging the share base.
For most issuers the result is a spiral of repeated equity issuance that constantly dilutes existing shareholders; only rarely does the instrument help a company cross a genuinely difficult patch. The pattern is well documented enough that France's market regulator, the AMF, warned the public in a detailed note in July 2020 about the risks inherent in these vehicles. In response, some groups have moved to non-dilutive or cash-settled synthetic convertibles, while the classic OCABSA remains very common among penny stocks.
Why Conversion, Warrants and the Indemnity Clause Compound the Damage
The Mechanics That Turn a Bridge Loan Into a Dilution Spiral
The defining feature is speed. Subscribers pay the full amount at issuance, so the company receives cash at once; but the subscriber's incentive is to convert into shares at a discount to the prevailing market price and resell them immediately, capturing the spread. The source states that this is what the majority of subscribers do. Verified: this conversion-and-resale flow puts downward pressure on the issuer's share price. Interpretation: because a company turns to this product precisely when it is in difficulty and its stock is weak, the pressure arrives at the worst possible moment and makes each successive financing round cheaper for subscribers but costlier for the company.
The BSA warrants extend the impact beyond the bond's short maturity. They give the holder the right to subscribe to new shares at a fixed price over a longer period, which issuers can treat as gradual reinforcement of equity. Verified: each subscription increases the share count and reduces the share of future profits redistributed to existing shareholders. Interpretation: the structure aligns the subscriber's profit with continued dilution, which is the opposite of what existing shareholders want.
Where the Indemnity Clause Makes a Bad Deal Worse
The most damaging element is not always the dilution. Verified: some OCABSA include an indemnity clause under which, if the share price falls below the nominal value of the shares, the issuer may owe compensation to the subscriber — potentially more than the amount of financing received. Interpretation: this clause is anti-cyclical in the worst way: it loads a bigger liability on the company exactly when its stock has collapsed, which is the same scenario that triggers the clause. Conversion pressure helps cause the share-price decline, and the decline then generates an additional payment to the subscriber. A company that was already unable to borrow can therefore end up paying more for the financing than it raised.
The AMF Warning and the Shift to Non-Dilutive Alternatives
Verified: in July 2020 the AMF published a detailed note alerting the public to the risks inherent in these vehicles. Some groups have since circumvented the problem by issuing non-dilutive convertibles — synthetic convertible bonds repaid in cash, under which subscribers receive the cash equivalent of the market value of the shares at conversion rather than the shares themselves. The source also notes that equity lines are statistically less penalizing for shareholders than other structures, while OCABSA are very widespread among penny stocks. Interpretation: the regulator's warning and the migration toward cash-settled structures show that the market recognises the damage, but the product has not disappeared — it has concentrated among the smallest, most vulnerable issuers, where retail investors are most exposed.
Five Red Flags for Investors When a Small Cap Issues Dilutive Paper
For investors holding or considering small-cap and penny-stock positions, this explainer translates into concrete checks when a company announces any equity-linked financing.
- Treat an OCABSA, OCA, equity line or PACEO announcement as a sign that ordinary credit is closed: the source notes these instruments are typically issued by companies that have lost access to borrowing or cannot raise capital on good terms.
- Scrutinise the conversion price and speed: the source states subscribers convert quickly and resell immediately at a discount to the market price — the wider that discount, the stronger the expected pressure on the share price.
- Check for warrants: longer-dated BSA keep additional share issuance open after the bond matures, so the dilution does not necessarily end at maturity.
- Look specifically for the indemnity clause: if the share price falls below nominal value, the issuer may owe compensation that exceeds the financing it received — a clause that turns a falling share price into a growing liability.
- Prefer structures that avoid dilution: the source notes some issuers have moved to synthetic, cash-settled convertibles, and that equity lines are statistically less penalizing to shareholders than OCABSA.
Risk & Opportunity Assessment
| Commercial Risk | High | Issuers are usually already cut off from credit; conversion discounts and immediate resale pressure the share price, and the indemnity clause can make the total cost exceed the cash raised. |
| Competitive Risk | Medium | Repeated dilutive issuance erodes the equity base and market value, weakening the issuer's ability to fund operations and investment compared with rivals that retain normal access to capital. |
| Regulatory Risk | Medium | The AMF issued a detailed public warning in July 2020 about the risks of these vehicles; further disclosure requirements or restrictions remain possible, though none are cited in the source. |
| Reputation Risk | High | Issuers of OCABSA are widely associated with distress — the source notes the product is very common among penny stocks and has intermittently featured in negative financial chronicles since 2015. |
| Technology Disruption | Low | No technology shift is involved; the disruptive factor is financial engineering in the form of conversion and warrant mechanics, not innovation. |
| Commercial Opportunity | Medium | For subscribing funds, the conversion discount creates a reliable arbitrage opportunity; for issuers, OCABSA deliver immediate cash when bank credit and standard capital increases are unavailable — though the source's track record suggests the long-run cost usually outweighs the benefit. |
Comments 0